BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33971263)

  • 1. Metabolic regulation on the immune environment of glioma through gut microbiota.
    Lyu Y; Yang H; Chen L
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):990-997. PubMed ID: 33971263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis.
    Ma Q; Xing C; Long W; Wang HY; Liu Q; Wang RF
    J Neuroinflammation; 2019 Mar; 16(1):53. PubMed ID: 30823925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice.
    D'Alessandro G; Antonangeli F; Marrocco F; Porzia A; Lauro C; Santoni A; Limatola C
    Eur J Immunol; 2020 May; 50(5):705-711. PubMed ID: 32034922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of gut microbiota in patients with benign and malignant brain tumors: a pilot study.
    Jiang H; Zeng W; Zhang X; Pei Y; Zhang H; Li Y
    Bioengineered; 2022 Mar; 13(3):7847-7859. PubMed ID: 35291914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
    Parodi B; Kerlero de Rosbo N
    Front Immunol; 2021; 12():718220. PubMed ID: 34621267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication.
    Silva YP; Bernardi A; Frozza RL
    Front Endocrinol (Lausanne); 2020; 11():25. PubMed ID: 32082260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kynurenine pathway metabolism and the microbiota-gut-brain axis.
    Kennedy PJ; Cryan JF; Dinan TG; Clarke G
    Neuropharmacology; 2017 Jan; 112(Pt B):399-412. PubMed ID: 27392632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
    Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
    Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioma and the gut-brain axis: opportunities and future perspectives.
    Dono A; Nickles J; Rodriguez-Armendariz AG; McFarland BC; Ajami NJ; Ballester LY; Wargo JA; Esquenazi Y
    Neurooncol Adv; 2022; 4(1):vdac054. PubMed ID: 35591978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vagotomy and insights into the microbiota-gut-brain axis.
    Liu Y; Forsythe P
    Neurosci Res; 2021 Jul; 168():20-27. PubMed ID: 33887355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microbiota-immune axis as a central mediator of gut-brain communication.
    Fung TC
    Neurobiol Dis; 2020 Mar; 136():104714. PubMed ID: 31846737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supplementation with a high-glucose drink stimulates anti-tumor immune responses to glioblastoma via gut microbiota modulation.
    Kim J; Kim Y; La J; Park WH; Kim HJ; Park SH; Ku KB; Kang BH; Lim J; Kwon MS; Lee HK
    Cell Rep; 2023 Oct; 42(10):113220. PubMed ID: 37804509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota: A new insight into lung diseases.
    Ma PJ; Wang MM; Wang Y
    Biomed Pharmacother; 2022 Nov; 155():113810. PubMed ID: 36271581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The function of gut microbiota in immune-related neurological disorders: a review.
    Sittipo P; Choi J; Lee S; Lee YK
    J Neuroinflammation; 2022 Jun; 19(1):154. PubMed ID: 35706008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNS.
    Liu L; Huh JR; Shah K
    EBioMedicine; 2022 Mar; 77():103908. PubMed ID: 35255456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan.
    Snigdha S; Ha K; Tsai P; Dinan TG; Bartos JD; Shahid M
    Pharmacol Ther; 2022 Mar; 231():107978. PubMed ID: 34492236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microbiota-gut-brain axis in sleep disorders.
    Wang Z; Wang Z; Lu T; Chen W; Yan W; Yuan K; Shi L; Liu X; Zhou X; Shi J; Vitiello MV; Han Y; Lu L
    Sleep Med Rev; 2022 Oct; 65():101691. PubMed ID: 36099873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism.
    Gao J; Xu K; Liu H; Liu G; Bai M; Peng C; Li T; Yin Y
    Front Cell Infect Microbiol; 2018; 8():13. PubMed ID: 29468141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.